The expression of S100A4 in human pancreatic cancer is associated with invasion

Pancreas

Volumn 42, Issue 6, 2013, Pages 1027-1033

  Tsukamoto, Nobukazu ^a   Egawa, Shinichi ^a   Akada, Masanori ^a   Abe, Keiko ^a   Saiki, Yuriko ^a   Kaneko, Naoyuki ^a   Yokoyama, Satoru ^a   Shima, Kentaro ^a   Yamamura, Akihiro ^a   Motoi, Fuyuhiko ^a   Abe, Hisashi ^a   Hayashi, Hiroki ^a   Ishida, Kazuyuki ^b   Moriya, Takuya ^b   Tabata, Takahiro ^a   Kondo, Emiko ^a   Kanai, Naomi ^a   Gu, Zhaodi ^a   Sunamura, Makoto ^a,c   Unno, Michiaki ^a   Horii, Akira ^a   more..

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY HOSPITAL   (Japan)

^c TOKYO MEDICAL UNIVERSITY HACHIOJI MEDICAL CENTER   (Japan)

Author keywords

clinicopathologic significance; immunohistochemistry; pancreatic cancer; S100A4; tissue microarray; TP53

Indexed keywords

CALVASCULIN; CD133 ANTIGEN; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CARCINOGENESIS; DISEASE ASSOCIATION; HUMAN; HUMAN CELL; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; PANCREAS CANCER; PERINEURAL INVASION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR INVASION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; BLOTTING, WESTERN; CARCINOMA, PANCREATIC DUCTAL; CELL LINE, TUMOR; GLYCOPROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEOPLASM INVASIVENESS; PANCREATIC NEOPLASMS; PEPTIDES; PROGNOSIS; S100 PROTEINS; TISSUE ARRAY ANALYSIS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84880680413     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e31828804e7     Document Type: Article

References (39)

1. Bardeesy N, DePinho RA. Pancreatic cancer biology and genetics. Nat Rev Cancer. 2002;2:897-909.
2. Marenholz I, Heizmann CW, Fritz G. S100 proteins in mouse and man: from evolution to function and pathology (including an update of the nomenclature). Biochem Biophys Res Commun. 2004;322:1111-1122.
3. Li ZH, Bresnick AR. The S100A4 metastasis factor regulates cellular motility via a direct interaction with myosin-IIA. Cancer Res. 2006;66:5173-5180.
4. Tarabykina S, Griffiths TRL, Tulchinsky E, et al. Metastasis-associated protein S100A4: spotlight on its role in cell migration. Curr Cancer Drug Targets. 2007;7:217-228.
5. Mazzucchelli L. Protein S100A4: too long overlooked by pathologists? Am J Pathol. 2002;160:7-13.
6. Ryu B, Jones J, Blades NJ, et al. Relationships and differentially expressed genes among pancreatic cancers examined by large-scale serial analysis of gene expression. Cancer Res. 2002;62:819-826.
7. Rosty C, Ueki T, Argani P, et al. Overexpression of S100A4 in pancreatic ductal adenocarcinomas is associated with poor differentiation and DNA hypomethylation. Am J Pathol. 2002;160:45-50.
8. Tabata T, Tsukamoto N, Imani Fooladi AA, et al. RNA interference targeting against S100A4 suppresses cell growth and motility and induces apoptosis in human pancreatic cancer cells. Biochem Biophys Res Commun. 2009;390:475-480.
9. Kondo E, Horii A, Fukushige S. The human PMS2L proteins do not interact with hMLH1, a major DNA mismatch repair protein. J Biochem. 1999;125:818-825.
10. Takenaga K, Nakanishi H, Wada K, et al. Increased expression of S100A4, a metastasis-associated gene, in human colorectal adenocarcinomas. Clin Cancer Res. 1997;3:2309-2316.
11. Japan Pancreas Society. Classification of Pancreatic Cancer, Second English Edition. Tokyo, Japan: Kanehara; 2003.
12. Matsuno S, Egawa S, Fukuyama S, et al. Pancreatic Cancer Registry in Japan: 20 years of experience. Pancreas. 2004;28:219-230.
13. Nieto J, Grossbard ML, Kozuch P. Metastatic Pancreatic Cancer 2008: is the glass less empty? Oncologist. 2008;13:562-576.
14. Bjørnland K, Winberg JO, Odegaard OT, et al. S100A4 Involvement in metastasis: deregulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in osteosarcoma cells transfected with an anti-S100A4 ribozyme. Cancer Res. 1999;59:4702-4708.
15. Kim EJ, Helfman DM. Characterization of the metastasis-associated protein, S100A4. J Biol Chem. 2003;278:30063-30073.
16. Helfman DM, Kim EJ, Lukanidin E, et al. The metastasis associated protein S100A4: role in tumour progression and metastasis. Br J Cancer. 2005;92:1955-1958.
17. Garrett SC, Varney KM, Weber DJ, et al. S100A4, a mediator of metastasis. J Biol Chem. 2006;281:677-680.
18. Matsubara D, Niki T, Ishikawa S, et al. Differential expression of S100A2 and S100A4 in lung adenocarcinomas: clinicopathological significance, relationship to p53 and identification of their target genes. Cancer Sci. 2005;96:844-857.
19. Rudland PS, Platt-Higgins A, Renshaw C, et al. Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer. Cancer Res. 2000;60:1595-1603.
20. Platt-Higgins AM, Renshaw CA, West CR, et al. Comparison of the metastasis-inducing protein S100A4 (p9ka) with other prognostic markers in human breast cancer. Int J Cancer. 2000;89:198-208.
21. Zou M, Al-Baradie RS, Al-Hindi H, et al. S100A4 (Mts1) gene overexpression is associated with invasion and metastasis of papillary thyroid carcinoma. Br J Cancer. 2005;93:1277-1284.
22. Ikenaga N, Ohuchida K, Mizumoto K, et al. S100A4 mRNA is a diagnostic and prognostic marker in pancreatic carcinoma. J Gastrointest Surg. 2009;13:1852-1858.
23. Missiaglia E, Blaveri E, Terris B, et al. Analysis of gene expression in cancer cell lines identifies candidate markers for pancreatic tumorigenesis and metastasis. Int J Cancer. 2004;112:100-112.
24. Yonemura Y, Endou Y, Kimura K, et al. Inverse expression of S100A4 and E-cadherin is associated with metastatic potential in gastric cancer. Clin Cancer Res. 2000;6:4234-4242.
25. Gongoll S, Peters G, Mengel M, et al. Prognostic significance of calcium-binding protein S100A4 in colorectal cancer. Gastroenterology. 2002;123:1478-1484.
26. Ninomiya I, Ohta T, Fushida S, et al. Increased expression of S100A4 and its prognostic significance in esophageal squamous cell carcinoma. Int J Oncol. 2001;18:715-720.
27. Lee WY, Su WC, Lin PW, et al. Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer. Oncology. 2004;66:429-438.
28. Ai KX, Lu LY, Huang XY, et al. Prognostic significance of S100A4 and vascular endothelial growth factor expression in pancreatic cancer. World J Gastroenterol. 2008;14:1931-1935.
29. Sekine H, Chen N, Sato K, et al. S100A4, frequently overexpressed in various human cancers, accelerates cell motility in pancreatic cancer cells. Biochem Biophys Res Commun. 2012;429:214-219.
30. Schmidt-Hansen B, Klingelhöfer J, Grum-Schwensen B, et al. Functional significance of metastasis-inducing S100A4 (Mts1) in tumor-stroma interplay. J Biol Chem. 2004;279:24498-24504.
31. Cabezón T, Celis JE, Skibshøj I, et al. Expression of S100A4 by a variety of cell types present in the tumor microenvironment of human breast cancer. Int J Cancer. 2007;121:1433-1444.
32. Hermann PC, Huber SL, Herrler T, et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell. 2007;1:313-323.
33. Barton CM, Staddon SL, Hughes CM, et al. Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer. Br J Cancer. 1991;64:1076-1082.
34. Nakamori S, Yashima K, Murakami Y, et al. Association of p53 gene mutations with short survival in pancreatic adenocarcinoma. Jpn J Cancer Res. 1995;86:174-181.
35. Yatsuoka T, Sunamura M, Furukawa T, et al. Association of poor prognosis with loss of 12q, 17p, and 18q, and concordant loss of 6q/17p and 12q/18q in human pancreatic ductal adenocarcinoma. Am J Gastroenterol. 2000;95:2080-2085.
36. Furukawa T, Sunamura M, Horii A. Molecular mechanisms of pancreatic carcinogenesis. Cancer Sci. 2006;97:1-7.
37. Nakamura Y. Isolation of p53-target genes and their functional analysis. Cancer Sci. 2004;95:7-11.
38. Fernandez-Fernandez MR, Veprintsev DB, et al. Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor. Proc Natl Acad Sci USA. 2005;102: 4735-4740.
39. Grigorian M, Andresen S, Tulchinsky E, et al. Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein. J Biol Chem. 2001;276:22699-22708.